{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T18:14:02Z","timestamp":1787163242810,"version":"build-2736575974"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2017,4,22]],"date-time":"2017-04-22T00:00:00Z","timestamp":1492819200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Surg Today"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1007\/s00595-017-1531-9","type":"journal-article","created":{"date-parts":[[2017,4,22]],"date-time":"2017-04-22T01:44:23Z","timestamp":1492825463000},"page":"1434-1442","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Predictive risk factors for peritoneal recurrence after pancreatic cancer resection and strategies for its prevention"],"prefix":"10.1007","volume":"47","author":[{"given":"Kyohei","family":"Ariake","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fuyuhiko","family":"Motoi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideo","family":"Ohtsuka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koji","family":"Fukase","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kunihiro","family":"Masuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masamichi","family":"Mizuma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroki","family":"Hayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kei","family":"Nakagawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takanori","family":"Morikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shimpei","family":"Maeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatsuyuki","family":"Takadate","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Naitoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinichi","family":"Egawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michiaki","family":"Unno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,4,22]]},"reference":[{"issue":"1","key":"1531_CR1","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1097\/SLA.0b013e31825ffbfb","volume":"257","author":"KE Poruk","year":"2013","unstructured":"Poruk KE, Firpo MA, Adler DG, Mulvihill SJ. Screening for pancreatic cancer: why, how, and who? Ann Surg. 2013;257(1):17\u201326.","journal-title":"Ann Surg"},{"key":"1531_CR2","doi-asserted-by":"publisher","DOI":"10.1007\/s00595-017-1495-9","author":"Y Fukuda","year":"2017","unstructured":"Fukuda Y, Yamada D, Eguchi H, Iwagami Y, Noda T, Asaoka T, et al. A novel preoperative predictor of pancreatic fistula by using computed tomography after distal pancreatectomy with staple closure. Surg Today. 2017. doi:\n                        10.1007\/s00595-017-1495-9\n                        \n                    .","journal-title":"Surg Today"},{"issue":"6","key":"1531_CR3","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1007\/s00595-015-1236-x","volume":"46","author":"H Katayama","year":"2016","unstructured":"Katayama H, Kurokawa Y, Nakamura K, Ito H, Kanemitsu Y, Masuda N, et al. Extended Clavien\u2013Dindo classification of surgical complications: Japan Clinical Oncology Group postoperative complications criteria. Surg Today. 2016;46(6):668\u201385.","journal-title":"Surg Today"},{"issue":"9","key":"1531_CR4","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1245\/s10434-006-9032-x","volume":"13","author":"P Massucco","year":"2006","unstructured":"Massucco P, Capussotti L, Magnino A, Sperti E, Gatti M, Muratore A, et al. Pancreatic resections after chemoradiotherapy for locally advanced ductal adenocarcinoma: analysis of perioperative outcome and survival. Ann Surg Oncol. 2006;13(9):1201\u20138.","journal-title":"Ann Surg Oncol"},{"issue":"3","key":"1531_CR5","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1097\/SLA.0000000000001850","volume":"264","author":"T Hackert","year":"2016","unstructured":"Hackert T, Sachsenmaier M, Hinz U, Schneider L, Michalski CW, Springfeld C, et al. Locally advanced pancreatic cancer: neoadjuvant therapy with FOLFIRINOX results in resectability in 60% of the patients. Ann Surg. 2016;264(3):457\u201363.","journal-title":"Ann Surg"},{"issue":"12","key":"1531_CR6","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1056\/NEJMoa032295","volume":"350","author":"JP Neoptolemos","year":"2004","unstructured":"Neoptolemos JP, Stocken DD, Friess H, Bassi C, Dunn JA, Hickey H, et al. A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer. N Engl J Med. 2004;350(12):1200\u201310.","journal-title":"N Engl J Med"},{"issue":"5","key":"1531_CR7","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1097\/SLA.0b013e318156eef3","volume":"246","author":"HG Smeenk","year":"2007","unstructured":"Smeenk HG, van Eijck CH, Hop WC, Erdmann J, Tran KC, Debois M, et al. Long-term survival and metastatic pattern of pancreatic and periampullary cancer after adjuvant chemoradiation or observation: long-term results of EORTC trial 40891. Ann Surg. 2007;246(5):734\u201340.","journal-title":"Ann Surg"},{"issue":"4","key":"1531_CR8","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.gassur.2005.09.016","volume":"10","author":"S Hishinuma","year":"2006","unstructured":"Hishinuma S, Ogata Y, Tomikawa M, Ozawa I, Hirabayashi K, Igarashi S. Patterns of recurrence after curative resection of pancreatic cancer, based on autopsy findings. J Gastrointest Surg. 2006;10(4):511\u20138.","journal-title":"J Gastrointest Surg"},{"issue":"1","key":"1531_CR9","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1097\/01.mpa.0000166998.04266.88","volume":"31","author":"K Shibata","year":"2005","unstructured":"Shibata K, Matsumoto T, Yada K, Sasaki A, Ohta M, Kitano S. Factors predicting recurrence after resection of pancreatic ductal carcinoma. Pancreas. 2005;31(1):69\u201373.","journal-title":"Pancreas"},{"issue":"1","key":"1531_CR10","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1097\/SLA.0b013e31823d813c","volume":"255","author":"H Takahashi","year":"2012","unstructured":"Takahashi H, Ohigashi H, Ishikawa O, Gotoh K, Yamada T, Nagata S, et al. Perineural invasion and lymph node involvement as indicators of surgical outcome and pattern of recurrence in the setting of preoperative gemcitabine-based chemoradiation therapy for resectable pancreatic cancer. Ann Surg. 2012;255(1):95\u2013102.","journal-title":"Ann Surg"},{"issue":"1","key":"1531_CR11","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1111\/hpb.12058","volume":"16","author":"P Papavasiliou","year":"2014","unstructured":"Papavasiliou P, Hoffman JP, Cohen SJ, Meyer JE, Watson JC, Chun YS. Impact of preoperative therapy on patterns of recurrence in pancreatic cancer. HPB (Oxford). 2014;16(1):34\u20139.","journal-title":"HPB (Oxford)"},{"issue":"19","key":"1531_CR12","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1056\/NEJMoa1011923","volume":"364","author":"T Conroy","year":"2011","unstructured":"Conroy T, Desseigne F, Ychou M, Bouche O, Guimbaud R, Becouarn Y, et al. FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer. N Engl J Med. 2011;364(19):1817\u201325.","journal-title":"N Engl J Med"},{"issue":"18","key":"1531_CR13","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1056\/NEJMoa1304369","volume":"369","author":"DD Hoff Von","year":"2013","unstructured":"Von Hoff DD, Ervin T, Arena FP, Chiorean EG, Infante J, Moore M, et al. Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine. N Engl J Med. 2013;369(18):1691\u2013703.","journal-title":"N Engl J Med"},{"issue":"1","key":"1531_CR14","first-page":"103","volume":"238","author":"O Ishikawa","year":"2003","unstructured":"Ishikawa O, Wada H, Ohigashi H, Doki Y, Yokoyama S, Noura S, et al. Postoperative cytology for drained fluid from the pancreatic bed after \u201ccurative\u201d resection of pancreatic cancers: does it predict both the patient\u2019s prognosis and the site of cancer recurrence? Ann Surg. 2003;238(1):103\u201310.","journal-title":"Ann Surg"},{"issue":"2","key":"1531_CR15","first-page":"143","volume":"6","author":"M Hirota","year":"2005","unstructured":"Hirota M, Shimada S, Yamamoto K, Tanaka E, Sugita H, Egami H, et al. Pancreatectomy using the no-touch isolation technique followed by extensive intraoperative peritoneal lavage to prevent cancer cell dissemination: a pilot study. JOP. 2005;6(2):143\u201351.","journal-title":"JOP"},{"issue":"13","key":"1531_CR16","doi-asserted-by":"crossref","first-page":"4322","DOI":"10.1245\/s10434-013-3159-3","volume":"20","author":"MM Rochefort","year":"2013","unstructured":"Rochefort MM, Ankeny JS, Kadera BE, Donald GW, Isacoff W, Wainberg ZA, et al. Impact of tumor grade on pancreatic cancer prognosis: validation of a novel TNMG staging system. Ann Surg Oncol. 2013;20(13):4322\u20139.","journal-title":"Ann Surg Oncol"},{"issue":"9","key":"1531_CR17","doi-asserted-by":"crossref","first-page":"2312","DOI":"10.1245\/s10434-010-1071-7","volume":"17","author":"N Wasif","year":"2010","unstructured":"Wasif N, Ko CY, Farrell J, Wainberg Z, Hines OJ, Reber H, et al. Impact of tumor grade on prognosis in pancreatic cancer: should we include grade in AJCC staging? Ann Surg Oncol. 2010;17(9):2312\u201320.","journal-title":"Ann Surg Oncol"},{"issue":"2","key":"1531_CR18","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1007\/s00595-016-1405-6","volume":"47","author":"T Tomihara","year":"2017","unstructured":"Tomihara T, Eguchi H, Yamada D, Gotoh K, Kawamoto K, Wada H, et al. Preoperative chemoradiotherapy does not compromise the feasibility of adjuvant chemotherapy for patients with pancreatic ductal adenocarcinoma. Surg Today. 2017;47(2):218\u201326.","journal-title":"Surg Today"},{"issue":"1","key":"1531_CR19","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/MPA.0b013e3181f7147a","volume":"40","author":"S Nagai","year":"2011","unstructured":"Nagai S, Fujii T, Kodera Y, Kanda M, Sahin TT, Kanzaki A, et al. Impact of operative blood loss on survival in invasive ductal adenocarcinoma of the pancreas. Pancreas. 2011;40(1):3\u20139.","journal-title":"Pancreas"},{"issue":"2","key":"1531_CR20","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.jss.2010.05.059","volume":"166","author":"D Benson","year":"2011","unstructured":"Benson D, Barnett CC Jr. Perioperative blood transfusions promote pancreas cancer progression. J Surg Res. 2011;166(2):275\u20139.","journal-title":"J Surg Res"},{"issue":"3","key":"1531_CR21","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1245\/s10434-014-4060-4","volume":"22","author":"T Arita","year":"2015","unstructured":"Arita T, Ichikawa D, Konishi H, Komatsu S, Shiozaki A, Hiramoto H, et al. Increase in peritoneal recurrence induced by intraoperative hemorrhage in gastrectomy. Ann Surg Oncol. 2015;22(3):758\u201364.","journal-title":"Ann Surg Oncol"},{"issue":"6","key":"1531_CR22","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1007\/s00268-009-9979-4","volume":"33","author":"T Kamei","year":"2009","unstructured":"Kamei T, Kitayama J, Yamashita H, Nagawa H. Intraoperative blood loss is a critical risk factor for peritoneal recurrence after curative resection of advanced gastric cancer. World J Surg. 2009;33(6):1240\u20136.","journal-title":"World J Surg"},{"issue":"3","key":"1531_CR23","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1007\/s00280-016-2972-3","volume":"77","author":"H Ueno","year":"2016","unstructured":"Ueno H, Ikeda M, Ueno M, Mizuno N, Ioka T, Omuro Y, et al. Phase I\/II study of nab-paclitaxel plus gemcitabine for chemotherapy-naive Japanese patients with metastatic pancreatic cancer. Cancer Chemother Pharmacol. 2016;77(3):595\u2013603.","journal-title":"Cancer Chemother Pharmacol"},{"issue":"10","key":"1531_CR24","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1111\/cas.12501","volume":"105","author":"T Okusaka","year":"2014","unstructured":"Okusaka T, Ikeda M, Fukutomi A, Ioka T, Furuse J, Ohkawa S, et al. Phase II study of FOLFIRINOX for chemotherapy-naive Japanese patients with metastatic pancreatic cancer. Cancer Sci. 2014;105(10):1321\u20136.","journal-title":"Cancer Sci"},{"issue":"Suppl 3","key":"1531_CR25","doi-asserted-by":"crossref","first-page":"S1212","DOI":"10.1245\/s10434-015-4851-2","volume":"22","author":"U Nitsche","year":"2015","unstructured":"Nitsche U, Wenzel P, Siveke JT, Braren R, Holzapfel K, Schlitter AM, et al. Resectability after first-line FOLFIRINOX in initially unresectable locally advanced pancreatic cancer: a single-center experience. Ann Surg Oncol. 2015;22(Suppl 3):S1212\u201320.","journal-title":"Ann Surg Oncol"},{"issue":"5","key":"1531_CR26","doi-asserted-by":"crossref","first-page":"e65","DOI":"10.1016\/j.amjsurg.2008.06.035","volume":"199","author":"M Hirota","year":"2010","unstructured":"Hirota M, Kanemitsu K, Takamori H, Chikamoto A, Tanaka H, Sugita H, et al. Pancreatoduodenectomy using a no-touch isolation technique. Am J Surg. 2010;199(5):e65\u20138.","journal-title":"Am J Surg"},{"issue":"5","key":"1531_CR27","first-page":"1321","volume":"27","author":"K Yamamoto","year":"2005","unstructured":"Yamamoto K, Shimada S, Hirota M, Yagi Y, Matsuda M, Baba H. EIPL (extensive intraoperative peritoneal lavage) therapy significantly reduces peritoneal recurrence after pancreatectomy in patients with pancreatic cancer. Int J Oncol. 2005;27(5):1321\u20138.","journal-title":"Int J Oncol"},{"issue":"2","key":"1531_CR28","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1097\/SLA.0b013e3181b0c80e","volume":"250","author":"M Kuramoto","year":"2009","unstructured":"Kuramoto M, Shimada S, Ikeshima S, Matsuo A, Yagi Y, Matsuda M, et al. Extensive intraoperative peritoneal lavage as a standard prophylactic strategy for peritoneal recurrence in patients with gastric carcinoma. Ann Surg. 2009;250(2):242\u20136.","journal-title":"Ann Surg"}],"container-title":["Surgery Today"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00595-017-1531-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00595-017-1531-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00595-017-1531-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,10,30]],"date-time":"2017-10-30T13:36:09Z","timestamp":1509370569000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00595-017-1531-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4,22]]},"references-count":28,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["1531"],"URL":"https:\/\/doi.org\/10.1007\/s00595-017-1531-9","relation":{},"ISSN":["0941-1291","1436-2813"],"issn-type":[{"value":"0941-1291","type":"print"},{"value":"1436-2813","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,4,22]]}}}